As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...
CatDRX is a generative AI framework developed at Institute of Science Tokyo, which enables the design of new chemical catalysts based on the specific chemical reactions in which they are used. The ...
Researchers develop an AI-based platform that integrates reaction data with catalyst performance for the design of new ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
With climate change posing an unprecedented global challenge, the demand for environmentally friendly solvents in green ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback